Global Pets Anti-infective Drugs Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Pets Anti-infective Drugs Market
Leptospirosis, staphylococcal infection, bacterial ear infection, actinomycosis, and nocardiosis are some of the most common forms of infections in pets. Moreover, pets are susceptible to bacterial diseases, such as plague, brucellosis, and Lyme disease. Anti-infectives is a general term used to describe any medicine that is capable of inhibiting the spread of an organism infectious or by killing the infectious organism outright.This term encompasses antibiotics, antifungals etc.

Due to the COVID-19 pandemic, the global Pets Anti-infective Drugs market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, External Use accounting for % of the Pets Anti-infective Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Dog segment is altered to an % CAGR throughout this forecast period.

In the China market, core pets anti-infective drugs manufacturers include Zoetis, Merck and Elanco etc. The Top 3 companies hold a share above 40%.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Administration Method

External Use

Internal Use

Injection

Segment by Application

Dog

Cat

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Pets Anti-infective Drugs market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Zoetis

Merck

Elanco

Virbac

Dechra Veterinary Products

Ceva Santé Animale

Vetoquinol

Nanjing Jindun Animal

Wuhan Chopperlvya

Bimeda Animal Health

Ouro Fino Saude

Norbrook

TABLE OF CONTENT

1 Study Coverage
1.1 Pets Anti-infective Drugs Product Introduction

1.2 Market by Administration Method

1.2.1 Global Pets Anti-infective Drugs Market Size Growth Rate by Administration Method, 2017 VS 2021 VS 2028

1.2.2 External Use

1.2.3 Internal Use

1.2.4 Injection

1.3 Market by Application

1.3.1 Global Pets Anti-infective Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Dog

1.3.3 Cat

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Pets Anti-infective Drugs Sales Estimates and Forecasts 2017-2028

2.2 Global Pets Anti-infective Drugs Revenue Estimates and Forecasts 2017-2028

2.3 Global Pets Anti-infective Drugs Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Pets Anti-infective Drugs Sales by Region

2.4.1 Global Pets Anti-infective Drugs Sales by Region (2017-2022)

2.4.2 Global Sales Pets Anti-infective Drugs by Region (2023-2028)

2.5 Global Pets Anti-infective Drugs Revenue by Region

2.5.1 Global Pets Anti-infective Drugs Revenue by Region (2017-2022)

2.5.2 Global Pets Anti-infective Drugs Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Pets Anti-infective Drugs Sales by Manufacturers

3.1.1 Global Top Pets Anti-infective Drugs Manufacturers by Sales (2017-2022)

3.1.2 Global Pets Anti-infective Drugs Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pets Anti-infective Drugs in 2021

3.2 Global Pets Anti-infective Drugs Revenue by Manufacturers

3.2.1 Global Pets Anti-infective Drugs Revenue by Manufacturers (2017-2022)

3.2.2 Global Pets Anti-infective Drugs Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Pets Anti-infective Drugs Revenue in 2021

3.3 Global Pets Anti-infective Drugs Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Pets Anti-infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Pets Anti-infective Drugs Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Administration Method

4.1 Global Pets Anti-infective Drugs Sales by Administration Method

4.1.1 Global Pets Anti-infective Drugs Historical Sales by Administration Method (2017-2022)

4.1.2 Global Pets Anti-infective Drugs Forecasted Sales by Administration Method (2023-2028)

4.1.3 Global Pets Anti-infective Drugs Sales Market Share by Administration Method (2017-2028)

4.2 Global Pets Anti-infective Drugs Revenue by Administration Method

4.2.1 Global Pets Anti-infective Drugs Historical Revenue by Administration Method (2017-2022)

4.2.2 Global Pets Anti-infective Drugs Forecasted Revenue by Administration Method (2023-2028)

4.2.3 Global Pets Anti-infective Drugs Revenue Market Share by Administration Method (2017-2028)

4.3 Global Pets Anti-infective Drugs Price by Administration Method

4.3.1 Global Pets Anti-infective Drugs Price by Administration Method (2017-2022)

4.3.2 Global Pets Anti-infective Drugs Price Forecast by Administration Method (2023-2028)

5 Market Size by Application

5.1 Global Pets Anti-infective Drugs Sales by Application

5.1.1 Global Pets Anti-infective Drugs Historical Sales by Application (2017-2022)

5.1.2 Global Pets Anti-infective Drugs Forecasted Sales by Application (2023-2028)

5.1.3 Global Pets Anti-infective Drugs Sales Market Share by Application (2017-2028)

5.2 Global Pets Anti-infective Drugs Revenue by Application

5.2.1 Global Pets Anti-infective Drugs Historical Revenue by Application (2017-2022)

5.2.2 Global Pets Anti-infective Drugs Forecasted Revenue by Application (2023-2028)

5.2.3 Global Pets Anti-infective Drugs Revenue Market Share by Application (2017-2028)

5.3 Global Pets Anti-infective Drugs Price by Application

5.3.1 Global Pets Anti-infective Drugs Price by Application (2017-2022)

5.3.2 Global Pets Anti-infective Drugs Price Forecast by Application (2023-2028)

6 North America

6.1 North America Pets Anti-infective Drugs Market Size by Administration Method

6.1.1 North America Pets Anti-infective Drugs Sales by Administration Method (2017-2028)

6.1.2 North America Pets Anti-infective Drugs Revenue by Administration Method (2017-2028)

6.2 North America Pets Anti-infective Drugs Market Size by Application

6.2.1 North America Pets Anti-infective Drugs Sales by Application (2017-2028)

6.2.2 North America Pets Anti-infective Drugs Revenue by Application (2017-2028)

6.3 North America Pets Anti-infective Drugs Market Size by Country

6.3.1 North America Pets Anti-infective Drugs Sales by Country (2017-2028)

6.3.2 North America Pets Anti-infective Drugs Revenue by Country (2017-2028)

6.3.3 United States

6.3.4 Canada

7 Europe

7.1 Europe Pets Anti-infective Drugs Market Size by Administration Method

7.1.1 Europe Pets Anti-infective Drugs Sales by Administration Method (2017-2028)

7.1.2 Europe Pets Anti-infective Drugs Revenue by Administration Method (2017-2028)

7.2 Europe Pets Anti-infective Drugs Market Size by Application

7.2.1 Europe Pets Anti-infective Drugs Sales by Application (2017-2028)

7.2.2 Europe Pets Anti-infective Drugs Revenue by Application (2017-2028)

7.3 Europe Pets Anti-infective Drugs Market Size by Country

7.3.1 Europe Pets Anti-infective Drugs Sales by Country (2017-2028)

7.3.2 Europe Pets Anti-infective Drugs Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Pets Anti-infective Drugs Market Size by Administration Method

8.1.1 Asia Pacific Pets Anti-infective Drugs Sales by Administration Method (2017-2028)

8.1.2 Asia Pacific Pets Anti-infective Drugs Revenue by Administration Method (2017-2028)

8.2 Asia Pacific Pets Anti-infective Drugs Market Size by Application

8.2.1 Asia Pacific Pets Anti-infective Drugs Sales by Application (2017-2028)

8.2.2 Asia Pacific Pets Anti-infective Drugs Revenue by Application (2017-2028)

8.3 Asia Pacific Pets Anti-infective Drugs Market Size by Region

8.3.1 Asia Pacific Pets Anti-infective Drugs Sales by Region (2017-2028)

8.3.2 Asia Pacific Pets Anti-infective Drugs Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 China Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

9 Latin America

9.1 Latin America Pets Anti-infective Drugs Market Size by Administration Method

9.1.1 Latin America Pets Anti-infective Drugs Sales by Administration Method (2017-2028)

9.1.2 Latin America Pets Anti-infective Drugs Revenue by Administration Method (2017-2028)

9.2 Latin America Pets Anti-infective Drugs Market Size by Application

9.2.1 Latin America Pets Anti-infective Drugs Sales by Application (2017-2028)

9.2.2 Latin America Pets Anti-infective Drugs Revenue by Application (2017-2028)

9.3 Latin America Pets Anti-infective Drugs Market Size by Country

9.3.1 Latin America Pets Anti-infective Drugs Sales by Country (2017-2028)

9.3.2 Latin America Pets Anti-infective Drugs Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Pets Anti-infective Drugs Market Size by Administration Method

10.1.1 Middle East and Africa Pets Anti-infective Drugs Sales by Administration Method (2017-2028)

10.1.2 Middle East and Africa Pets Anti-infective Drugs Revenue by Administration Method (2017-2028)

10.2 Middle East and Africa Pets Anti-infective Drugs Market Size by Application

10.2.1 Middle East and Africa Pets Anti-infective Drugs Sales by Application (2017-2028)

10.2.2 Middle East and Africa Pets Anti-infective Drugs Revenue by Application (2017-2028)

10.3 Middle East and Africa Pets Anti-infective Drugs Market Size by Country

10.3.1 Middle East and Africa Pets Anti-infective Drugs Sales by Country (2017-2028)

10.3.2 Middle East and Africa Pets Anti-infective Drugs Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Zoetis

11.1.1 Zoetis Corporation Information

11.1.2 Zoetis Overview

11.1.3 Zoetis Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Zoetis Pets Anti-infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Zoetis Recent Developments

11.2 Merck

11.2.1 Merck Corporation Information

11.2.2 Merck Overview

11.2.3 Merck Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Merck Pets Anti-infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Merck Recent Developments

11.3 Elanco

11.3.1 Elanco Corporation Information

11.3.2 Elanco Overview

11.3.3 Elanco Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Elanco Pets Anti-infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Elanco Recent Developments

11.4 Virbac

11.4.1 Virbac Corporation Information

11.4.2 Virbac Overview

11.4.3 Virbac Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Virbac Pets Anti-infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Virbac Recent Developments

11.5 Dechra Veterinary Products

11.5.1 Dechra Veterinary Products Corporation Information

11.5.2 Dechra Veterinary Products Overview

11.5.3 Dechra Veterinary Products Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Dechra Veterinary Products Pets Anti-infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Dechra Veterinary Products Recent Developments

11.6 Ceva Santé Animale

11.6.1 Ceva Santé Animale Corporation Information

11.6.2 Ceva Santé Animale Overview

11.6.3 Ceva Santé Animale Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.6.4 Ceva Santé Animale Pets Anti-infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Ceva Santé Animale Recent Developments

11.7 Vetoquinol

11.7.1 Vetoquinol Corporation Information

11.7.2 Vetoquinol Overview

11.7.3 Vetoquinol Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.7.4 Vetoquinol Pets Anti-infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Vetoquinol Recent Developments

11.8 Nanjing Jindun Animal

11.8.1 Nanjing Jindun Animal Corporation Information

11.8.2 Nanjing Jindun Animal Overview

11.8.3 Nanjing Jindun Animal Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.8.4 Nanjing Jindun Animal Pets Anti-infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Nanjing Jindun Animal Recent Developments

11.9 Wuhan Chopperlvya

11.9.1 Wuhan Chopperlvya Corporation Information

11.9.2 Wuhan Chopperlvya Overview

11.9.3 Wuhan Chopperlvya Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.9.4 Wuhan Chopperlvya Pets Anti-infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Wuhan Chopperlvya Recent Developments

11.10 Bimeda Animal Health

11.10.1 Bimeda Animal Health Corporation Information

11.10.2 Bimeda Animal Health Overview

11.10.3 Bimeda Animal Health Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.10.4 Bimeda Animal Health Pets Anti-infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Bimeda Animal Health Recent Developments

11.11 Ouro Fino Saude

11.11.1 Ouro Fino Saude Corporation Information

11.11.2 Ouro Fino Saude Overview

11.11.3 Ouro Fino Saude Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.11.4 Ouro Fino Saude Pets Anti-infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Ouro Fino Saude Recent Developments

11.12 Norbrook

11.12.1 Norbrook Corporation Information

11.12.2 Norbrook Overview

11.12.3 Norbrook Pets Anti-infective Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.12.4 Norbrook Pets Anti-infective Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Norbrook Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Pets Anti-infective Drugs Industry Chain Analysis

12.2 Pets Anti-infective Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Pets Anti-infective Drugs Production Mode & Process

12.4 Pets Anti-infective Drugs Sales and Marketing

12.4.1 Pets Anti-infective Drugs Sales Channels

12.4.2 Pets Anti-infective Drugs Distributors

12.5 Pets Anti-infective Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Pets Anti-infective Drugs Industry Trends

13.2 Pets Anti-infective Drugs Market Drivers

13.3 Pets Anti-infective Drugs Market Challenges

13.4 Pets Anti-infective Drugs Market Restraints

14 Key Findings in The Global Pets Anti-infective Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample